 |
Addiction Volume 115, Issue 7 Pages: 1201-1408 July 2020
|
Issue Information
Editorial
Extra‐medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?
Pages: 1203-1205 | First Published: 14 September 2019
Editorial Note
Addiction Opinion and Debate
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
Pages: 1207-1216 | First Published: 12 October 2019
Commentaries on Freeman & Lorenzetti (2020)
How experimental cannabinoid studies will inform the standardized THC unit
Pages: 1217-1218 | First Published: 05 February 2020
Open Access
Importance of a standard unit dose for cannabis research
Pages: 1219-1221 | First Published: 21 February 2020
Standard tetrahydrocannabinol units: an idea whose time has come
Pages: 1221-1222 | First Published: 07 April 2020
Open Access
Moving forwards with the standard THC unit
Pages: 1222-1223 | First Published: 30 May 2020
Reviews
Effect of alcohol use disorders and alcohol intake on the risk of subsequent depressive symptoms: a systematic review and meta‐analysis of cohort studies
Pages: 1224-1243 | First Published: 14 December 2019
Open Access
The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa
Pages: 1244-1262 | First Published: 03 February 2020
Commentary on Mahmud et al. (2020): Hepatitis C elimination efforts need to include people who inject drugs in the Middle East and North Africa
Pages: 1263-1264 | First Published: 15 April 2020
Research Reports
Titrated baclofen for high‐risk alcohol consumption: a randomized placebo‐controlled trial in out‐patients with 1‐year follow‐up
Pages: 1265-1276 | First Published: 13 December 2019
Toxic trade: the impact of preferential trade agreements on alcohol imports from Australia in partner countries
Pages: 1277-1284 | First Published: 05 December 2019
Relationships between US state alcohol policies and alcohol outcomes: differences by gender and race/ethnicity
Pages: 1285-1294 | First Published: 05 February 2020
Open Access
Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
Pages: 1295-1305 | First Published: 20 December 2019
Commentary on Larance et al. (2020): Priorities and concerns of people who use opioids are key to scaling up XR‐buprenorphine
Pages: 1306-1307 | First Published: 18 April 2020
Using contributing causes of death improves prediction of opioid involvement in unclassified drug overdoses in US death records
Pages: 1308-1317 | First Published: 27 February 2020
Commentary on Boslett et al. (2020): Towards better measurement of drug involvement in fatal overdoses
Pages: 1318-1319 | First Published: 27 February 2020
Self‐reported exposure to, perceptions about, and attitudes about public marijuana smoking among US adults, 2018
Pages: 1320-1329 | First Published: 03 January 2020